We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14.9B
AUM Growth
+$734M
(+5.2%)
Cap. Flow
-$271M
Cap. Flow
% of AUM
-1.83%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
304
New
43
Increased
101
Reduced
105
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$215M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Microsoft
MSFT
|
+$163M |
| 4 |
Biogen
BIIB
|
+$147M |
| 5 |
Synchrony
SYF
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$236M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$227M |
| 3 |
AbbVie
ABBV
|
+$169M |
| 4 |
Yum! Brands
YUM
|
+$147M |
| 5 |
Analog Devices
ADI
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.21% |
| 2 | Technology | 15.59% |
| 3 | Consumer Discretionary | 15.51% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 11.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Bankunited
BKU
$3.43B
| $67M | 0.45% |
1,857,190
-141,299
| -7% | -$5.25M |
|
77
Dentsply Sirona
XRAY
$2.76B
| $66.8M | 0.45% |
1,098,469
+378,767
| +53% | +$22.5M |
|
78
Mettler-Toledo International
MTD
$28.5B
| $66.8M | 0.45% |
196,955
-3,699
| -2% | -$1.19M |
|
|
TMH
79
DELISTED
Team Health Holdings Inc
TMH
| $65.2M | 0.44% |
1,485,037
-4,884
| -0.3% | -$259K |
|
80
Vulcan Materials
VMC
$37.2B
| $64.4M | 0.43% |
678,448
-94,226
| -12% | -$9.13M |
|
81
PTC Therapeutics
PTCT
$5.78B
| $60.7M | 0.41% |
1,872,220
+621,079
| +50% | +$18.3M |
|
|
SCS
82
DELISTED
Steelcase
SCS
| $60.3M | 0.41% |
4,044,271
+2,166,972
| +115% | +$40.8M |
|
|
ARIA
83
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $59.3M | 0.4% |
9,493,458
-140,006
| -1% | -$919K |
|
84
Signet Jewelers
SIG
$3.75B
| $58.7M | 0.4% |
474,573
-21,838
| -4% | -$2.96M |
|
|
WBC
85
DELISTED
WABCO HOLDINGS INC.
WBC
| $58.5M | 0.39% |
572,040
+5,915
| +1% | +$629K |
|
86
ManpowerGroup
MAN
$2.53B
| $58.2M | 0.39% |
690,700
-29,589
| -4% | -$2.59M |
|
87
Raymond James Financial
RJF
$34.7B
| $58M | 0.39% |
1,502,031
-86,370
| -5% | -$3.22M |
|
|
MACK
88
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $57.3M | 0.39% |
922,214
+94,595
| +11% | +$6.66M |
|
89
Netflix
NFLX
$309B
| $57.1M | 0.38% |
4,995,990
-158,030
| -3% | -$1.81M |
|
|
AMAG
90
DELISTED
AMAG Pharmaceuticals
AMAG
| $55.2M | 0.37% |
1,827,052
-59,853
| -3% | -$1.93M |
|
|
QLIK
91
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $54.9M | 0.37% |
1,734,857
-9,308
| -0.5% | -$305K |
|
|
BXLT
92
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $54.8M | 0.37% |
+1,403,966
| New | +$48.9M |
|
|
WMGI
93
DELISTED
Wright Medical Group Inc
WMGI
| $54.4M | 0.37% |
2,251,539
-151,094
| -6% | -$3.27M |
|
94
Acadia Pharmaceuticals
ACAD
$4.93B
| $52.7M | 0.36% |
+1,479,504
| New | +$52.1M |
|
95
Sabre
SABR
$838M
| $52.3M | 0.35% |
1,869,370
-883,580
| -32% | -$25.6M |
|
96
Starwood Property Trust
STWD
$6.01B
| $51.8M | 0.35% |
2,521,185
-1,232,536
| -33% | -$25.3M |
|
|
FRC
97
DELISTED
First Republic Bank
FRC
| $51.7M | 0.35% |
782,991
-131,629
| -14% | -$8.7M |
|
98
Pacira BioSciences
PCRX
$979M
| $51.4M | 0.35% |
669,560
-719,604
| -52% | -$40.7M |
|
99
MSCI
MSCI
$41.6B
| $51.2M | 0.34% |
+709,625
| New | +$47.4M |
|
100
CBRE Group
CBRE
$43.8B
| $49.8M | 0.33% |
1,438,835
-11,472
| -0.8% | -$404K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Westfield Capital Management held 304 positions worth $14.9B, up 5.2% from $14.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Westfield Capital Management's Q4 2015 filing shows 43 new, 101 increased, 105 reduced and 32 closed positions. Its largest new stake was Alphabet (Google) Class A: 5,804,860 shares worth $226M. The largest sale was Vertex Pharmaceuticals, an estimated $236M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,804,860 shares worth $226M.
- Westfield Capital Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $184M increase.
- Westfield Capital Management's biggest Q4 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $236M.
- Westfield Capital Management fully exited Analog Devices in Q4 2015, selling an estimated $129M.
- Westfield Capital Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2015.
- Westfield Capital Management opened 43 new positions and closed 32 in Q4 2015.
- Westfield Capital Management's portfolio value rose 5.2% quarter-over-quarter to $14.9B.
Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.